Publications by authors named "Miguel Angel Molina-Vila"

37Publications

Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells.

Transl Oncol 2021 Jan 23;14(1):100887. Epub 2020 Oct 23.

Instituto Oncológico Dr. Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain; Catalan Institute of Oncology, Badalona, Spain; Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.

View Article and Find Full Text PDF
January 2021

Clinical Benefit From BRAF/MEK Inhibition in a Double Non-V600E BRAF Mutant Lung Adenocarcinoma: A Case Report.

Clin Lung Cancer 2019 05 4;20(3):e219-e223. Epub 2019 Mar 4.

Department of Medical Oncology, Hospital Clínic, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Electronic address:

View Article and Find Full Text PDF
May 2019

Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation.

EBioMedicine 2019 Feb 20;40:92-105. Epub 2019 Jan 20.

Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address:

View Article and Find Full Text PDF
February 2019

Anti-Epidermal Growth Factor Vaccine Antibodies Enhance the Efficacy of Tyrosine Kinase Inhibitors and Delay the Emergence of Resistance in EGFR Mutant Lung Cancer Cells.

J Thorac Oncol 2018 09 8;13(9):1324-1337. Epub 2018 May 8.

Instituto Oncológico Dr. Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain; Catalan Institute of Oncology and Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.

View Article and Find Full Text PDF
September 2018

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes.

Sci Rep 2018 05 4;8(1):7072. Epub 2018 May 4.

Department of Biochemistry, Radboud Institute for Molecular Life Sciences, University Medical Centre, Nijmegen, 6525 GA, The Netherlands.

View Article and Find Full Text PDF
May 2018

RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.

Arch Pathol Lab Med 2018 Apr;142(4):474-479

From the Department of Pathology, Hospital Clínic, Barcelona, Spain (Dr Teixidó); Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (Dr Teixidó); Pangaea Oncology, Oncology Laboratory, Dexeus University Hospital - Quirónsalud Group, Barcelona, Spain (Ms Giménez-Capitán and Drs Molina-Vila, Peg, Karachaliou, Castellví, and Rosell); the Department of Pathology, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain (Drs Peg and Castellví); Morphological Sciences Department, Universitat Autònoma de Barcelona, Barcelona, Spain (Drs Peg and Castellví); Institute of Oncology Rosell (IOR), University Hospital Sagrat Cor and Quirónsalud Group, Barcelona, Spain (Drs Karachaliou and Rosell); the Department of Medical Oncology, Canarias University Hospital, San Cristóbal de La Laguna, Tenerife, Spain (Dr Rodríguez-Capote); and Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain (Dr Rosell).

View Article and Find Full Text PDF
April 2018